Opthea Ltd
Price Chart
OHLC · volume · moving averages
Market Statistics
Today's trading range
Valuation
Fundamental multiples
Trading Activity
Volume & order book
Performance
Returns across timeframes
Technical Indicators
Momentum & moving averages
— From the desk
Latest News
Opthea achieves positive vision trial, eyes further clinical trials
Biopharmaceutical company Opthea (ASX: OPT) has taken an affirmative step towards commercialising its OPT-302 combination therapy after publishing positive phase 2b clinical trial results that included 366 patients. With the results published the biopharma company claims that PT-302 may emerge as a combination treatment that can offer better vision gains than currently available care with […]
Opthea starts trial for OPT-302 drug in diabetic eye diseases
Biopharmaceutical company Opthea (ASX: OPT) has started a Phase 1b/2a trial investigating the effectiveness of its OPT-302 drug in diabetic eye diseases. Diabetic macular edema leads to the thickening of the retina caused by leaky blood vessels. The disease is the leading cause of blindness in diabetes and affects more than two million people around […]